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Human skin ﬁbroblasts (ATCC #CRL 2429) were plated at a
density of 100,000 cells per 35mm cell culture dish. The reprogramming
strategy was based on a modiﬁcation of the Y4 episomal approach
(Okita et al.). Plasmids for the reprogramming pCXLE-hOCT3/4 -
shp53pCXLE -hULpCXLE were purchased from Addgene, Middlesex,
UK. In our modiﬁed protocol, subconﬂuent ﬁbroblasts were transfected
with the episomes using lipofectamine 2000 (LifeSciences, #11668,
Invitrogen, Carlsbad, CA, USA), according to the manufacturers' proto-
col. 48 h post-transfection, cells were refreshedwith ﬁbroblast medium
(IMDM #30–2005, supplemented with 10% fetal bovine serum/FBS
#16000-044, Gibco, Gaithersburg, USA). On day 4 cells were fed
with serum containing embryonic stem cell medium (Knockout
DMEM/F12 #12660, 15% FBS #16000-044, 1% Non-Essential Amino
Acids/NEAA #11140, 1% Glutamax #35050, 1 × 2-mercaptoethanol
#21985023 all from Gibco, supplemented with 40 ng/ml bfgf #100-
18B, Peprotech, Rochy Hill, USA) which was refreshed daily, for the
next two days. On day 6, this cell population was trypsinized and
reseeded 1:7 on irradiated ﬁbroblasts(#GSC-6301G, GlobalStem, Ox-
fordshire, UK) to boost reprogramming. On day 8 cells were grown in
serum free embryonic stem cell medium (Knockout DMEM/F12
#12660, 15% KnockOut Serum Replacement #10828 -Gibco, 1%
NEAA, 1% Glutamax, supplemented with 1 × 2-mercaptoethanol
and 20 ng/ml bfgf) and the medium was changed daily. From day
12 to Day 20 cells were fed with conditioned serum-free embryonic
stem cell medium from feeders, to sustain pre-formed human in-
duced pluripotent (pre-hiPS) colonies' growth. On day 20, pre-hiPSthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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grown on matrigel (dilution 1:100, # 354277, BD Biosciences,
Oxford, UK) with mTeSR medium (#05850, Stem Cell Technologies,
Vancouver, Canada). Thereafter, hiPS colonies were manually
dissected “en block” and expanded in feeder free and serum free con-
ditions (Fig. 1A).Fig. 1.Generation and validation of hiPS. A) Reprogramming strategy, B) immunoﬂuorescence a
Oct3/4, Sox2, Nanog, Alkaline phosphatase, SSEA4, and E-Cadherin stem cell markers. Propidium
based test for the validation of integration-free hiPS lines was performed targeting the EBNA-1 s
vector and another primer set for the endogenous locus FBXO15. The generated hiPS lines sho
stability with no evidence of chromosomal abnormalities, E) Heat map analysis of the differ
ﬁbroblasts (hFs) and embryonic HUES1 stem cell line. All hiPS lines show heat map genet
examination of teratoma tissues: i) cartilage, ii) tubular glands and smooth muscle tissue (g
v) stratiﬁed squamous epithelium, vi) ciliated epithelium, vii) embryonic neurons with small d2. Veriﬁcation and authentication
2.1. Phenotypic characterization of hiPS
Successful reprogramming of initial ﬁbroblasts towards induced
pluripotency was evaluated by immunostaining with key pluripotencynalysis of generated hiPS for embryonic stem cell markers. hiPS colonies were positive for
iodidewas used to stain cell nucleus. C) Footprint analysis of generated hiPS lines. A PCR-
equence derived from the Epstein-Barr virus to calculate the copy number of the episomal
w no episomal footprint. D) Comparative genomic hybridisation analysis shows genetic
entially regulated genes following reprogramming among hiPSC lines, original human
ic proﬁle identical to embryonic HUES and different from original hFs. F) Histological
ut-like structure), iii) cartilage (purple) and smooth muscle (red) tissue, iv) ganglion,
endrites and axons, viii) GI tract tubular glands.
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coated chamber-slide system (LabTek #177437). Cells were ﬁxed with
either ice coldMethanol or paraformaldehyde 3.7% (followedbyperme-
abilization with 0.1% Triton for 4 min). After blocking with 5% donkey
serum, cells were stained with antibodies recognizing stem markers
for 1 h at the following concentrations: Oct3/4 (1:300), Nanog
(1:100), Sox2 (1:100), Alkaline Phosphatase (1:100), SSEA4 (1:100)
and Ε cadherin (1:300) (Suppl. Table 1). After washing, secondary anti-
bodies FITC donkey α-mouse or FITC donkey α-goat were added for
45 min, followed by 30 min incubation with 1 mg RNAse (Sigma-
Aldrich, Hertfordshire, UK) and 20 min with propidium iodide (Sigma-
Aldrich, dilution 1:5000). Samples weremountedwith Prolong antifade
reagent (Invitrogen, Life Technologies) and imaging was performed
with a Leica TCS SP5 (10× dry objective).
2.2. Genotyping
High-resolution array-based comparative genomic hybridization
(CGH) (Centre of molecular biology and cytogenetics AlphaLab,
Greece) showed that hiPSC lines had no indication for copy number var-
iations and were therefore chromosomally stable (Fig. 1C). Moreover,
PCR screening of the genomic DNA, using primers speciﬁc for the
EBNA1 amplicon of the episomes used, veriﬁed footprint-free genera-
tion (Fig. 1D).
2.3. Whole transcriptome analysis
To validate the comparable transcriptional proﬁle of the gener-
ated hiPS lines versus human embryonic stem cells (HUES1 line,
NIH repository), we proceeded with whole transcriptome analysis,
accessible in the Gene Expression Omnibus (GEO) of NCBI(#GSE58932). Quality-assessed RNA samples were hybridized to
Affymetrix ExonExprChip.HuGene-1 arrays (EMBL-GeneCore,
Heidelberg, Germany). Normalized data underwent statistical analysis
(GeneSpring Software) to determine differentially expressed genes
(p ≤ 0.05 and fold change ≥ 2). A differential expression of approximate-
ly 3300 genes was observed between hiPSCs and control embryonic
stem cell line HUES1 versus the initially transduced ﬁbroblasts
(heatmap in Fig. 1E).
2.4. Differentiation
To ensure full pluripotency we carried out teratoma assays in
immune-deﬁcient NOD/SCID mice, maintained under SPF conditions
(Animal facility of the Academy of Athens, Greece). Aftermanual dissec-
tion of hiPS andHUES1 cultures (each froma subconﬂuent 35mmdish),
cell clumpswere centrifuged and resuspended in 100 μl of hES-qualiﬁed
matrigel, just prior to injection. The cell-matrigel mix was injected
through 25G 7/8 needle (BD Biosciences) subcutaneously in the hind
legs of the mice. Transplanted animals developed tumors within a
month and histopathological examination yielded tissue derivatives
from all three germ lines: ectoderm,mesoderm and endoderm (Fig. 1F).
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.scr.2016.05.006.
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